Cancer drug reduces death risk in hospitalized COVID-19 patients and 11 other recent related-research findings

The use of sabizabulin, a cancer drug, reduced the risk of death by 55 percent in patients hospitalized with COVID-19, a small study published July 6 in the New England Journal of Medicine found.